Call Us: 1.800.873.5297

By

Birth Control Pills Linked to Increase in Blood Clots

Yaz and Yasmin are popular birth control pills that differ only in dose. These drugs are referred to as “fourth generation” birth control pills; they contain a new type of synthetic progestin called “drospirenone.” For many years now, these two pills have been prescribed to prevent pregnancy and to reduce water retention and bloating, two of the most common symptoms of Premenstrual Dysphoric Disorder (PMDD), a condition millions of women suffer from each time they get their menstrual cycle. The Food and Drug Administration has announced that Yaz and Yasmin raise the level of potassium in your blood to a dangerous level. Increased serum potassium levels can lead to:

  • Stroke
  • Heart attack
  • Pancreatitis
  • Blood clots in the legs (DVT—deep vein thrombosis)
  • Blood clots in the lungs (pulmonary embolism)
  • Gall bladder disease

Increased risk of blood clots?

Two recent studies have found significantly increased risks associated with Yaz and Yasmin over other types of birth control pills. The first assessed the risk of venous thrombosis (blood clots) in women who take hormonal contraception was conducted on women ages 15-49 with no history of heart disease or any other malignant disease. The study found that of the 3.3 million women taking oral contraceptives, there were 4,213 venous thrombotic events. Of those, 2,045 occurred in women currently taking oral contraceptives.

The study found that oral contraceptives containing drospirenone, such as Yaz and Yasmin, were associated with a much higher risk of venous thrombosis than traditional oral contraceptives, which contain levonorgestrel rather than drospirenone. To read the full study, click here.

The second study found that Yaz and Yazmin users have twice the risk of a clotting event than users of birth control pills that contain levonorgestral. To read this study, click here.

At the time of this writing, the FDA has received 50 reports of death associated with Yaz and/or Yasmin during the four-year period 2004 to 2008. Women as young as 17 have died due to blood clots, stroke, and cardiac arrest. If you are taking either one of these birth control pills, you should contact your doctor immediately to discuss its safety.

Yaz and Yazmin are combination hormone contraceptives manufactured by Bayer Healthcare.

Schlichter, Bogard & Denton is a national leader in pharmaceutical litigation and is currently reviewing cases of women harmed by Yaz and Yazmin. The consequences of taking a dangerous drug can be devastating. We are prepared to handle the most complex dangerous drug cases, and we have successfully represented thousands of people all over the country in pharmaceutical litigation cases. We can help you, too.

Please contact the experienced pharmaceutical litigation attorneys at Schlichter, Bogard & Denton today. One of our attorneys will review your case and advise you of how best to proceed.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.